Rua Bioscience first NZX IPO of the year

Rua Bioscience first NZX IPO of the year
Brent Melville
Rua Bioscience chair Trevor Burt says the pharmaceutical grade cannabis firm will seek to raise $20 million via a listing on the NZX on Oct. 22 in the first initial public offering of the year. The East Coast based firm - an early recipient for a commercial medicinal production licence - will sell up to 40 million shares at 50 cents a share, representing 28.6 percent of the company in what will be the NZX's first IPO since Napier Port listed last year and the second cannabis firm, following Cannasouth's debut last June. Rua wi...

More Health

Beef tallow startup brothing with excitement
Retail

Beef tallow startup brothing with excitement

From garage to national shelves, this startup is making the most of beef bones.

Technology is making the war on cancer winnable
Health

Technology is making the war on cancer winnable

Malignancies have become treatable, even curable.

WasteCo’s truck/toilet plan, Radius wants to grow West Coast
Markets Small Cap Wrap

WasteCo’s truck/toilet plan, Radius wants to grow West Coast

Plus: who got more money from investors, who tapped a twosome, and more.

Digital Investment Plan expected this month
Policy

Digital Investment Plan expected this month

Health NZ to release its 10-year Digital Investment Plan in Christchurch.

Cécile Meier 14 Nov 2025